Find Out More About Liver Cancer Clinical Trials

Bile duct cancer is a particularly aggressive form of cancer with an extremely high mortality rate. Being diagnosed too late makes the prospect of successful treatment even harder. For some patients, experimental clinical trials might provide a cure. This form of gallbladder cancer clinical trials attempts to find new treatment for cancer patients by trying to kill cancer cells, improve on existing treatments or minimize side effects.

The most common clinical trial is a lung cancer phase I/II trial, which tests the effects of anti-cancer drugs in reducing the risks of patients developing either adenocarcinoma (the precursor of duct cancers) or leiomyosarcoma, both of which have high incidence rates in the elderly. Lung cancer is a disease in which abnormal tissue enlarges the bronchial airways and obstructs normal airflow. Drugs that aim to shrink adenocarcinomas may also be beneficial. Researchers conduct these clinical trials to determine the effect of anti-cancer drugs on the behavior of the human immune system and the function of the lymph nodes.

An alternative treatment used in the stage IIIA of cancer is to use immunotherapy, which involves using immune system suppressants to fight cancer cells. Drugs are usually injected into the brash glands of the lungs or into the pericardium, a sac that protects the heart. Immunotherapy trials can either be single shots to target one area of the immune system or multiple sessions spread over many months. Sometimes, a doctor can reduce the risk of developing cancer by combining different approaches to fight cancer. For example, some studies have found that exposing mice to tumors caused by the herpes simplex virus boosts the mice's ability to fight cancer.

There are two types of duct cancers: parietal and interstitial. They can be located in the liver, the small intestine, the pancreas, the spleen, or the abdomen. Although liver cancer accounts for the vast majority of duct cancers, they are also found in other areas, including the bladder, kidney, lungs, and small intestines. Interstitial duct cancers are less common than parietal ones, although they account for a large percentage of all interstitial cancers. Small intestine cancer is the least common type of ductular carcinoma, which accounts for around 5% of all cases.

Liver cancer cells live in ducts that connect the liver to the small intestine, the colon, or the blood. When cancer cells invade this space, they can spread to other parts of the body and even to the lymph nodes. To treat this condition, surgeons perform a surgical procedure to remove the ducts containing the cancer cells. One of the potential ways to remove them is through radiation therapy. Radiation therapy kills cancer cells by shrinking the ducts, allowing them to be removed surgically or haled with a laser.

Another possible type of ductal carcinoma is cholangiocarcinoma, which can affect the liver, pancreas, or any other part of the body. Unlike liver cancer, cholangiocarcinoma does not require surgery to remove the cancerous cells. This cancer is potentially fatal if not treated immediately, so early detection is crucial. The holangiocarcinoma treatment options can help patients cope with this life-threatening disease.

All Posts

Almost done…

We just sent you an email. Please click the link in the email to confirm your subscription!

OKSubscriptions powered by Strikingly